Remove 2027 Remove Communication Remove Vaccines
article thumbnail

Covid-19 vaccine success bolsters nanoparticle drug delivery research

Pharmaceutical Technology

Since then, the field of nanomedicine has steadily progressed to reach high points such as the successful use of nanotechnology to deliver messenger RNA (mRNA)-based Covid-19 vaccines. In the case of most mRNA vaccines, a lipid nanoparticle-based approach was chosen due to its ability to protect the mRNA in the body and prevent degradation.

article thumbnail

NHC Provides Input on Patient Engagement in Medicare Drug Price Negotiations

Putting Patients First Blog

The legislation included multiple provisions related to Medicare drug coverage including a $2000 cap on out-of-pocket drug costs, a $35/month insulin cap, and improved access to adult vaccines. Earlier this year CMS released draft guidance for Initial Payment Applicability Year (IPAY) 2027.

article thumbnail

High biologics demand spurs need for greater contract manufacturing

Pharmaceutical Technology

Demand for biologics, including vaccines, is at an all-time high, in the post-Covid era. There are fewer sites for cell and gene therapies and vaccines – 90 companies with 127 facilities, as per GlobalData figures. The approval of the mRNA Covid-19 vaccine, which is a biologic, has thrust the modality even further into the spotlight.